Success Metrics

Active Trials
0(0%)

Phase Distribution

Ph not_applicable
2
100%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution2 total trials
N/ANon-phased studies
2(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

2

all time

Status Distribution
Other(2)

Detailed Status

unknown2

Development Timeline

Analytics

Development Status

Total Trials
2
Active
0
Success Rate
N/A
Most Advanced
N/A

Trials by Phase

N/A2 (100.0%)

Trials by Status

unknown2100%

Recent Activity

0 active trials
Showing 2 of 2
unknownnot_applicable

Characterization of Myocardial Interstitial Fibrosis and Cardiomyocyte Hypertrophy by Cardiac MRI in Heart Failure

NCT03084679
unknownnot_applicable

Changes in Trunk Stability Indicators Following Two Types of Exhausting Physical Activities

NCT03529734

Clinical Trials (2)

Showing 2 of 2 trials
NCT03084679Not Applicable

Characterization of Myocardial Interstitial Fibrosis and Cardiomyocyte Hypertrophy by Cardiac MRI in Heart Failure

Unknown
NCT03529734Not Applicable

Changes in Trunk Stability Indicators Following Two Types of Exhausting Physical Activities

Unknown

All 2 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
2